Glenmark Gets DCGI Approval To Conduct Clinical Trials Of Favipiravir Anti-Viral Tablets On Covid-19 Patients

Glenmark said it is the first pharma company in India to get DCGI nod to start the trial on COVID-19 patients

from Swarajya https://ift.tt/2W4VSBK